Churchill Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,205
| Closed | -$903K | – | 160 |
|
|
2024
Q3 | $903K | Sell |
6,205
-1,054
| -15% | -$153K | 0.01% | 138 |
|
|
2024
Q2 | $996K | Sell |
7,259
-832
| -10% | -$111K | 0.01% | 141 |
|
|
2024
Q1 | $1.11M | Sell |
8,091
-609
| -7% | -$83.2K | 0.01% | 143 |
|
|
2023
Q4 | $1.18M | Sell |
8,700
-1,559
| -15% | -$190K | 0.02% | 128 |
|
|
2023
Q3 | $1.25M | Sell |
10,259
-15,458
| -60% | -$1.97M | 0.02% | 132 |
|
|
2023
Q2 | $3.27M | Sell |
25,717
-5,697
| -18% | -$740K | 0.06% | 108 |
|
|
2023
Q1 | $4.06M | Sell |
31,414
-6,672
| -18% | -$873K | 0.08% | 100 |
|
|
2022
Q4 | $5M | Sell |
38,086
-6,974
| -15% | -$901K | 0.12% | 84 |
|
|
2022
Q3 | $5.27M | Buy |
+45,060
| New | +$5.6M | 0.14% | 84 |
|
|
2021
Q4 | – | Sell |
-61,463
| Closed | -$9.94M | – | 145 |
|
|
2021
Q3 | $9.94M | Sell |
61,463
-4,012
| -6% | -$675K | 0.15% | 80 |
|
|
2021
Q2 | $10.7M | Sell |
65,475
-6,551
| -9% | -$1.01M | 0.16% | 83 |
|
|
2021
Q1 | $10.8M | Sell |
72,026
-1,137,326
| -94% | -$181M | 0.18% | 70 |
|
|
2020
Q4 | $183M | Buy |
1,209,352
+21,366
| +2% | +$3.05M | 3.12% | 11 |
|
|
2020
Q3 | $161M | Sell |
1,187,986
-415,853
| -26% | -$56.4M | 3.95% | 11 |
|
|
2020
Q2 | $219M | Buy |
1,603,839
+1,557,575
| +3,367% | +$199M | 6.81% | 4 |
|
|
2020
Q1 | $4.99M | Buy |
46,264
+1,028
| +2% | +$118K | 0.25% | 65 |
|
|
2019
Q4 | $5.45M | Buy |
+45,236
| New | +$5.05M | 0.1% | 88 |
|
|
2018
Q1 | – | Sell |
-1,801,330
| Closed | -$192M | – | 132 |
|
|
2017
Q4 | $192M | Buy |
1,801,330
+129,538
| +8% | +$13.8M | 4.22% | 9 |
|
|
2017
Q3 | $186M | Buy |
1,671,792
+161,556
| +11% | +$17.3M | 4.57% | 8 |
|
|
2017
Q2 | $156M | Buy |
+1,510,236
| New | +$149M | 4.08% | 8 |
|
|
2015
Q3 | – | Sell |
-1,005,534
| Closed | -$124M | – | 149 |
|
|
2015
Q2 | $124M | Sell |
1,005,534
-50,538
| -5% | -$6.05M | 4.4% | 6 |
|
|
2015
Q1 | $121M | Sell |
1,056,072
-19,467
| -2% | -$2.15M | 4.15% | 7 |
|
|
2014
Q4 | $109M | Sell |
1,075,539
-223,296
| -17% | -$21.7M | 4.32% | 7 |
|
|
2014
Q3 | $118M | Sell |
1,298,835
-485,040
| -27% | -$42.6M | 4.87% | 5 |
|
|
2014
Q2 | $153M | Buy |
1,783,875
+49,029
| +3% | +$3.86M | 6.9% | 3 |
|
|
2014
Q1 | $137M | Sell |
1,734,846
-38,175
| -2% | -$3.18M | 5.37% | 4 |
|
|
2013
Q4 | $134M | Buy |
1,773,021
+6,903
| +0.4% | +$490K | 5.15% | 7 |
|
|
2013
Q3 | $123M | Sell |
1,766,118
-56,427
| -3% | -$3.7M | 6.36% | 7 |
|
|
2013
Q2 | $106M | Buy |
+1,822,545
| New | +$105M | 4.93% | 8 |
|
Other funds holding IBB
Churchill Management's IBB Position: Q4 2024 in Review
Churchill Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 6,205 shares — an estimated $903K sold.
Churchill Management first reported a position in IBB in Q2 2013 and held it in 29 quarters. The position peaked at $219M in Q2 2020. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.
- Churchill Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
- Churchill Management sold 6,205 iShares Biotechnology ETF shares in Q4 2024, an estimated $903K.
- Churchill Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 29 quarters.
- Churchill Management's iShares Biotechnology ETF position peaked at $219M in Q2 2020.
- 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.
Based on Churchill Management's 13F filing for Q4 2024, filed 14 Jan 2025.